-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Maintains Outperform on Corbus Pharmaceuticals, Lowers Price Target to $23

Benzinga·11/12/2026 12:52:58
Listen to the news
Mizuho analyst Graig Suvannavejh maintains Corbus Pharmaceuticals (NASDAQ:CRBP) with a Outperform and lowers the price target from $24 to $23.